Health Care • Medical/Dental Instruments
$1.72 ▼ -0.02
(-1.15%)
MKT CAP: $13.0M • VOL: 9.5K
52W L $1 52W H $4
ROARABLE / RQD
D- • 37/100
PIOTROSKI
4 / 9
SINT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.0M | $2.9M | $2.6M |
| YoY Revenue Growth % | -64.7% | +9.9% | — |
| Gross Profit | $461.0K | $2.1M | — |
| Gross Margin % | 45.3% | 71.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$10.7M | -$14.0M | -$13.4M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$10.4M | -$11.0M | -$8.3M |
| EBITDA (Normalized) | -$10.6M | -$13.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$8.6M | -$8.6M | -$14.1M |
| Capital Expenditures (CapEx) | $185.0K | $690.0K | — |
| Free Cash Flow (FCF) | -$8.8M | -$9.3M | -$14.1M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $4.1M | $3.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $2.9M | $3.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SINT.